{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:35Z","timestamp":1790371055134,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270137"],"award-info":[{"award-number":["32270137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873438"],"award-info":[{"award-number":["81873438"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873922"],"award-info":[{"award-number":["81873922"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272142"],"award-info":[{"award-number":["82272142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jaci.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T19:28:14Z","timestamp":1682105294000},"page":"1622-1633.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease"],"prefix":"10.1016","volume":"151","author":[{"given":"Haodong","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoxin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5732-4848","authenticated-orcid":false,"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.04.003_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature10246","article-title":"Second messenger role for Mg2+ revealed by human T-cell immunodeficiency","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2023.04.003_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1240094","article-title":"Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D","volume":"341","author":"Chaigne-Delalande","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jaci.2023.04.003_bib3","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1182\/blood-2013-11-538686","article-title":"XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.04.003_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10875-014-0116-2","article-title":"Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease","volume":"35","author":"Dhalla","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2015.04.015","article-title":"A case of XMEN syndrome presented with severe auto-immune disorders mimicking autoimmune lymphoproliferative disease","volume":"159","author":"Patiroglu","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10875-016-0341-y","article-title":"Large deletion of MAGT1 gene in a patient with classic Kaposi sarcoma, CD4 lymphopenia, and EBV infection","volume":"37","author":"Brigida","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib7","first-page":"48","article-title":"[X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia: report of a family and literature review]","volume":"56","author":"He","year":"2018","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.jaci.2023.04.003_bib8","doi-asserted-by":"crossref","first-page":"9865","DOI":"10.1073\/pnas.1817815116","article-title":"Mutations in MAGT1 lead to a glycosylation disorder with a variable phenotype","volume":"116","author":"Blommaert","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2023.04.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-018-0573-0","article-title":"Successful bone marrow transplantation for XMEN: hemorrhagic risk uncovered","volume":"39","author":"Dimitrova","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI131116","article-title":"Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease","volume":"130","author":"Ravell","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2023.04.003_bib11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10875-020-00746-1","article-title":"The many faces of XMEN disease, report of two patients with novel mutations","volume":"40","author":"Hoyos-Bachiloglu","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10875-019-00732-2","article-title":"Diversity of XMEN disease: description of 2 novel variants and analysis of the lymphocyte phenotype","volume":"40","author":"Klinken","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcyt.2020.08.013","article-title":"MAGT1 messenger RNA\u2013corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease","volume":"23","author":"Brault","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaci.2023.04.003_bib14","article-title":"Further delineation of the spectrum of XMEN disease in six Chinese pediatric patients","volume":"13","author":"Peng","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.jaci.2023.04.003_bib15","article-title":"Novel MAGT1 mutation found in the first Chinese XMEN in Hong Kong","volume":"2022","author":"Au","year":"2022","journal-title":"Case Rep Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41435-022-00166-8","article-title":"Identification of a novel MAGT1 mutation supports a diagnosis of XMEN disease","volume":"23","author":"Watson","year":"2022","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaci.2023.04.003_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13154","article-title":"XMEN saved by magnesium","volume":"95","author":"Iyengar","year":"2022","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108722","article-title":"Cutaneous T-cell lymphoma as a unique presenting malignancy in X-linked magnesium defect with EBV infection and neoplasia (XMEN) disease","volume":"226","author":"Freeman","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00005-021-00635-4","article-title":"Molecular genetics diversity of primary hemophagocytic lymphohistiocytosis among Polish pediatric patients","volume":"69","author":"Babol-Pokora","year":"2021","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jaci.2023.04.003_bib20","article-title":"Case report: EBV-positive extra-nodal marginal zone lymphoma associated with XMEN disease caused by a novel hemizygous mutation in MAGT1","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaci.2023.04.003_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/21526567211056239","article-title":"Successful anti\u2013SARS-CoV-2 spike protein antibody response to vaccination in MAGT1 deficiency","volume":"12","author":"Jalil","year":"2021","journal-title":"Allergy Rhinol (Providence)"},{"key":"10.1016\/j.jaci.2023.04.003_bib22","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1074\/jbc.RA119.008903","article-title":"Magnesium transporter 1 (MAGT1) deficiency causes selective defects in N-linked glycosylation and expression of immune-response genes","volume":"294","author":"Matsuda-Lennikov","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2023.04.003_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10875-020-00790-x","article-title":"An update on XMEN disease","volume":"40","author":"Ravell","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00439-021-02400-1","article-title":"Lack of NKG2D in MAGT1-deficient patients is caused by hypoglycosylation","volume":"141","author":"Blommaert","year":"2022","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaci.2023.04.003_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10875-021-01137-w","article-title":"A double-blind, placebo-controlled, crossover study of magnesium supplementation in patients with XMEN disease","volume":"42","author":"Chauvin","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib26","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood.2021011192","article-title":"CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes","volume":"138","author":"Brault","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2023.04.003_bib27","doi-asserted-by":"crossref","first-page":"15750","DOI":"10.1073\/pnas.0908332106","article-title":"Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development","volume":"106","author":"Zhou","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2023.04.003_bib28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2164-6-48","article-title":"Identification and characterization of a novel mammalian Mg2+ transporter with channel-like properties","volume":"6","author":"Goytain","year":"2005","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jaci.2023.04.003_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1083\/jcb.201404083","article-title":"Oxidoreductase activity is necessary for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins","volume":"206","author":"Cherepanova","year":"2014","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2023.04.003_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep20946","article-title":"Mammalian cells lacking either the cotranslational or posttranslocational oligosaccharyltransferase complex display substrate-dependent defects in asparagine linked glycosylation","volume":"6","author":"Cherepanova","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2023.04.003_bib31","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1055-9965.EPI-14-1228","article-title":"Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer study","volume":"24","author":"Conway","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaci.2023.04.003_bib32","doi-asserted-by":"crossref","first-page":"84714","DOI":"10.18632\/oncotarget.20950","article-title":"Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer","volume":"8","author":"Burgermeister","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaci.2023.04.003_bib33","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1038\/sj.onc.1204433","article-title":"The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein","volume":"20","author":"Tobias","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jaci.2023.04.003_bib34","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/jcmm.13128","article-title":"TUSC3: a novel tumour suppressor gene and its functional implications","volume":"21","author":"Yu","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jaci.2023.04.003_bib35","doi-asserted-by":"crossref","first-page":"29208","DOI":"10.18632\/oncotarget.25673","article-title":"Circular RNA CpG island hypermethylation-associated silencing in human cancer","volume":"9","author":"Ferreira","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaci.2023.04.003_bib36","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/s41388-019-1032-y","article-title":"UHRF1-KAT7\u2013mediated regulation of TUSC3 expression via histone methylation\/acetylation is critical for the proliferation of colon cancer cells","volume":"39","author":"Taniue","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jaci.2023.04.003_bib37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jaci.2023.04.003_bib38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tree.2020.04.009","article-title":"The importance of genetic redundancy in evolution","volume":"35","author":"Laruson","year":"2020","journal-title":"Trends Ecol Evol"},{"key":"10.1016\/j.jaci.2023.04.003_bib39","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/gbe\/evy141","article-title":"Engineered functional redundancy relaxes selective constraints upon endogenous genes in viral RNA genomes","volume":"10","author":"Ambros","year":"2018","journal-title":"Genome Biol Evol"},{"key":"10.1016\/j.jaci.2023.04.003_bib40","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ajhg.2008.03.021","article-title":"Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation","volume":"82","author":"Molinari","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2023.04.003_bib41","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.1701467","article-title":"Cutting edge: imbalanced cation homeostasis in MAGT1-deficient B cells dysregulates B cell development and signaling in mice","volume":"200","author":"Gotru","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib42","first-page":"423","article-title":"Mechanisms of cell-damage and enzyme-release","volume":"41","author":"Kristensen","year":"1994","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.jaci.2023.04.003_bib43","first-page":"817","article-title":"The past and present of serum aminotransferases and the future of liver injury biomarkers","volume":"15","author":"McGill","year":"2016","journal-title":"EXCLI J"},{"key":"10.1016\/j.jaci.2023.04.003_bib44","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3748\/wjg.v21.i3.711","article-title":"Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine","volume":"21","author":"Sookoian","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaci.2023.04.003_bib45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5114\/ceji.2015.56168","article-title":"Combined immunodeficiencies: twenty years experience from a single center in Turkey","volume":"41","author":"Akar","year":"2016","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.jaci.2023.04.003_bib46","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","article-title":"CRISPR\/Cas9 for genome editing: progress, implications and challenges","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaci.2023.04.003_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","article-title":"CRISPR-Cas9 for cancer therapy: opportunities and challenges","volume":"447","author":"Chen","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jaci.2023.04.003_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2023.04.003_bib49","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/cncr.27850","article-title":"Methylation status of TUSC3 is a prognostic factor in ovarian cancer","volume":"119","author":"Pils","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jaci.2023.04.003_bib50","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00018-017-2660-4","article-title":"TUSC3: functional duality of a cancer gene","volume":"75","author":"Vasickova","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaci.2023.04.003_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.702360","article-title":"Small-molecule inhibitors overcome epigenetic reprogramming for cancer therapy","volume":"12","author":"Xiao","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2023.04.003_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113588","article-title":"Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy","volume":"222","author":"Duan","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jaci.2023.04.003_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41568-019-0109-9","article-title":"Epigenetic therapy in immune-oncology","volume":"19","author":"Jones","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaci.2023.04.003_bib54","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1021\/acs.jmedchem.0c02055","article-title":"Targeting epigenetic regulators with covalent small-molecule inhibitors","volume":"64","author":"Zhang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jaci.2023.04.003_bib55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/14656566.8.1.65","article-title":"The role of decitabine in the treatment of myelodysplastic syndromes","volume":"8","author":"Atallah","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaci.2023.04.003_bib56","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1158\/1078-0432.CCR-15-0530","article-title":"Panobinostat for the treatment of multiple myeloma","volume":"21","author":"Laubach","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2023.04.003_bib57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2146\/ajhp150487","article-title":"Panobinostat: a histone deacetylase inhibitor for the treatment of relapsed or refractory multiple myeloma","volume":"73","author":"Wahaib","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaci.2023.04.003_bib58","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/theoncologist.2017-0301","article-title":"EMA review of panobinostat (Farydak) for the treatment of adult patients with relapsed and\/or refractory multiple myeloma","volume":"23","author":"Tzogani","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.jaci.2023.04.003_bib59","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-16-3083","article-title":"Clinically relevant concentrations of anticancer drugs: a guide for nonclinical studies","volume":"23","author":"Liston","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2023.04.003_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-642-21631-2_2","article-title":"The biology of HDAC in cancer: the nuclear and epigenetic components","volume":"206","author":"Hagelkruys","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jaci.2023.04.003_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2023.04.003_bib62","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1517\/13543784.2013.815165","article-title":"Panobinostat in lymphoid and myeloid malignancies","volume":"22","author":"Khot","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2023.04.003_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.695093","article-title":"Could changing the DNA methylation landscape promote the destruction of Epstein-Barr virus\u2013associated cancers?","volume":"11","author":"Sinclair","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jaci.2023.04.003_bib64","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/molecules27061973","article-title":"A novel cognition of decitabine: insights into immunomodulation and antiviral effects","volume":"27","author":"Xiao","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jaci.2023.04.003_bib65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.critrevonc.2017.01.020","article-title":"Epigenetic control of gene expression: potential implications for cancer treatment","volume":"111","author":"Perri","year":"2017","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492300461X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009167492300461X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:43:54Z","timestamp":1758793434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009167492300461X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S009167492300461X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.04.003","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic activation of the TUSC3 gene as a potential therapy for XMEN disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}